Gabrielsen Discusses New State and Federal Efforts to Curb Prescription Opioid Abuse
February 8, 2018
Bloomberg BNA Health Law Resource Center
Associate Lindsey Gabrielsen is quoted in a Bloomberg BNA Health Law Resource Center article, “Doctors Feel the Pinch of Anti-Opioid Efforts,” about doctors’ efforts to comply with new state and federal limits on prescribing opioids.
Gabrielsen said the new limits can trip up physicians who don’t keep careful track of their prescribing history. “These government initiatives use data mining and data sharing to identify and target those physicians who prescribe more opioids than their peers, making them potential targets for government investigation,” she said.
She said doctors can take a number of practical steps to manage their opioid prescription risks, including taking the time to understand their state’s opioid prescribing laws. Focusing on documentation compliance is critical, she added. “If the government issues an investigatory subpoena for records, prescribers must be able to produce complete patient records containing notes with patient history, examination, and prescription information,” she said.
Gabrielsen said the new limits can trip up physicians who don’t keep careful track of their prescribing history. “These government initiatives use data mining and data sharing to identify and target those physicians who prescribe more opioids than their peers, making them potential targets for government investigation,” she said.
She said doctors can take a number of practical steps to manage their opioid prescription risks, including taking the time to understand their state’s opioid prescribing laws. Focusing on documentation compliance is critical, she added. “If the government issues an investigatory subpoena for records, prescribers must be able to produce complete patient records containing notes with patient history, examination, and prescription information,” she said.
Related News
August 8, 2025
In the News
Gregory Husisian and David Simon Uncover the High Stakes of Tariff Evasion
Foley & Lardner LLP partners Gregory Husisian and David Simon are featured for their insights on how the U.S. government is cracking down on tariff evaders in the Newsweek article, "America Is Making Billions From Catching 'Tariff Cheaters.'"
August 7, 2025
In the News
Kyle Faget Weighs in on Trump Pharma Tariffs
Foley & Lardner LLP partner Kyle Faget assessed the Trump administration's implementation of import tariffs on the pharmaceutical industry in the Pharma Life Sciences article, "Trump's pharma import tariffs threaten drug pricing, generics."
August 5, 2025
In the News
Aaron Maguregui on Health Data Sharing Plan – 'I would expect the FTC to be heavily involved'
Foley & Lardner LLP partner Aaron Maguregui addressed a new health care data sharing initiative announced by the federal government in the Bloomberg Law article, "Digital Data-Sharing Plan Tests Limits of Health Privacy Rules."